Nitric oxide-mediated corpus cavernosal smooth muscle relaxation is impaired in ageing and diabetes

BJU International

Volumn 87, Issue 4, 2001, Pages 394-401

  Cartledge, J J ^a   Eardley, I ^a   Morrison, J F B ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Advanced glycation end products; Corpus cavernosal smooth muscle; Diabetes; Impotence; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ARGININE; CARBON 11; INDOMETACIN; NITRIC OXIDE; PROSTANOID; SUPEROXIDE DISMUTASE;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DIABETES MELLITUS; ENDOTHELIUM CELL; GLYCATION; IN VITRO STUDY; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE RELAXATION;

ACETYLCHOLINE; AGING; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH; NITRIC OXIDE; NITROPRUSSIDE; NOREPINEPHRINE; PENIS; RATS; RATS, WISTAR;

EID: 0035073019     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2001.00065.x     Document Type: Article

References (33)

1. Report of the expert committee on the diagnosis and classification of diabetes mellitus
2. Impotence and its medical and psychological correlates: Results of the Massachusetts Male Aging Study
3. Sexual dysfunction in diabetic men
4. The prevalence of diabetic impotence
5. Prevalence of self-reported erectile dysfunction in people with long-term IDDM
6. Diabetic impotence: Risk factors in a clinic population
7. Physiology of erection
8. Hemodynamics of pelvic nerve induced erection in a canine model. II. Cavernosal inflow and occlusion
9. Impotence
10. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle
11. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle
12. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence
13. Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle
14. Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats
15. Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin
16. Endothelial and neuronal derived nitric oxide mediated relaxation of corpus cavernosal smooth muscle in a new rat, in vitro, model of erectile function
17. Biosynthesis and metabolism of endothelium-derived nitric oxide
18. Effect of chronic experimental diabetes on vascular smooth muscle function in rabbit carotid artery
19. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta
20. Alteration in endothelin B receptor sites in cavernosal tissue of diabetic rabbits: Potential relevance to the pathogenesis of erectile dysfunction
21. Functional effects, binding sites and immunolocalization of endothelin-1 in isolated penile tissues from man and rabbit
22. Vascular endothelial cells synthesize nitric oxide from L-arginine
23. Auto-radiographic localization of nitric oxide synthase binding sites in normal and diabetic rat corpus cavernosum
24. Diabetes mellitus increases nitric oxide synthase in penises but not in major pelvic ganglia of rats
25. Histopathological changes and nitric oxide synthase activity in corpus cavernosum from rats with neurogenie erectile dysfunction
26. Diabetes does not alter the activity and localisation of nitric oxide synthase in the rat anococcyfeus muscle
27. The effect of superoxide dismutase on nitric oxide-mediated and electrical field stimulated diabetic rabbit cavernosal smooth muscle relaxation
28. Hypercholesterolaemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase
29. Different distribution of caveolin-1 and caveolin-3 in the human corpus cavernosum: Immunohistochemical study, in comparison with nitric oxide synthase nerve and low affinity growth factor receptors
30. Pathogenic effects of advanced glycosylation: Biochemical, biologic, and clinical implications for diabetes and aging
31. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept
32. Age-related increases in an advanced glycation end product in penile tissue
33. Advanced glycation end products in human penis: Elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS